The DOI matches its Crossref record; 299 of the 299 references it cites were found in a registry or an index.
Recent Advances in Understanding the Pathogenesis of Rheumatoid Arthritis: New Treatment Strategies
Open accessAbstract
Rheumatoid arthritis (RA) is considered a chronic systemic, multi-factorial, inflammatory, and progressive autoimmune disease affecting many people worldwide. While patients show very individual courses of disease, with RA focusing on the musculoskeletal system, joints are often severely affected, leading to local inflammation, cartilage destruction, and bone erosion. To prevent joint damage and physical disability as one of many symptoms of RA, early diagnosis is critical. Auto-antibodies play a pivotal clinical role in patients with systemic RA. As biomarkers, they could help to make a more efficient diagnosis, prognosis, and treatment decision. Besides auto-antibodies, several other factors are involved in the progression of RA, such as epigenetic alterations, post-translational modifications, glycosylation, autophagy, and T-cells. Understanding the interplay between these factors would contribute to a deeper insight into the causes, mechanisms, progression, and treatment of the disease. In this review, the latest RA research findings are discussed to better understand the pathogenesis, and finally, treatment strategies for RA therapy are presented, including both conventional approaches and new methods that have been developed in recent years or are currently under investigation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–299 of 299
Reactivation of endogenous retroviral elements via treatment with DNMT- and HDAC-inhibitors
Daskalakis, M., Brocks, D., Sheng, Y.-H., Islam, S., Ressnerova, A., Assenov, Y., Milde, T., Oehme, I., Witt, O., Goyal, A., et al. (2018) · Cell Cycle · doi:10.1080/15384101.2018.1442623 · Cited by 91
Yan, F., Li, H., Zhong, Z., Zhou, M., Lin, Y., Tang, C., & Li, C. (2019) · International Journal of Nanomedicine · doi:10.2147/ijn.s219413 · Cited by 91
Curcumin in Autoimmune and Rheumatic Diseases
Yang, M., Akbar, U., & Mohan, C. (2019) · Nutrients · doi:10.3390/nu11051004 · Cited by 90
JÓNSSON, T., Steinsson, K., Jónsson, H., Geirsson, Á. J., Thorsteinsson, J., & Valdimarsson, H. (1998) · Rheumatology International · doi:10.1007/s002960050069 · Cited by 89
van Loosdregt, J., Rossetti, M. M., Spreafico, R., Moshref, M., Olmer, M., Williams, G. W., Kumar, P., Copeland, D., Pischel, K. D., Lotz, M., et al. (2016) · European Journal of Immunology · doi:10.1002/eji.201646375 · Cited by 89
The applications of anti-CD20 antibodies to treat various B cells disorders
Payandeh, Z., Bahrami, A. A., Hoseinpoor, R., Mortazavi, Y., Rajabibazl, M., Rahimpour, A., Taromchi, A. H., & Khalil, S. (2018) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.11.121 · Cited by 86
Self-citationLi, J., Hsu, H., Ding, Y., Li, H., Wu, Q., Yang, P., Luo, B., Rowse, A. L., Spalding, D. M., Bridges, S. L., et al. (2014) · Arthritis & Rheumatology · doi:10.1002/art.38711 · Cited by 85
Aletaha, D., Alasti, F., & Smolen, J. S. (2015) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2015-208324 · Cited by 85
Tanaka, H., Muto, A., Shima, H., Katoh, Y., Sax, N., Tajima, S., Brydun, A., Ikura, T., Yoshizawa-Sugata, N., Masai, H., et al. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.713842 · Cited by 85
Paglia, M. D. G., Silva, M. T., Lopes, L. C., Barberato-Filho, S., Mazzei, L. G., Abe, F. C., & Bergamaschi, C. D. C. (2021) · PLoS ONE · doi:10.1371/journal.pone.0248866 · Cited by 83
Bortezomib attenuates murine collagen-induced arthritis
Lee, S.-W., Kim, J.-H., Yb, P., & Lee, S.-K. (2008) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2008.097709 · Cited by 82
Safety with Ocrelizumab in Rheumatoid Arthritis: Results from the Ocrelizumab Phase III Program
Emery, P., Rigby, W. F. C., Tak, P. P., Dörner, T., Olech, E., Martín, C., Millar, L., Travers, H., & Fisheleva, E. (2014) · PLoS ONE · doi:10.1371/journal.pone.0087379 · Cited by 81
The Adaptor Protein p62 Is Involved in RANKL-induced Autophagy and Osteoclastogenesis
Li, R., Chen, G., Ren, J., Zhang, W., Wu, Z., Liu, B., Zhao, Y. F., & Zhao, Y. (2014) · Journal of Histochemistry & Cytochemistry · doi:10.1369/0022155414551367 · Cited by 80
Buhrmann, C., Shayan, P., Banik, K., Kunnumakkara, A. B., Kubatka, P., Koklesová, L., & Shakibaei, M. (2020) · Biomedicines · doi:10.3390/biomedicines8080236 · Cited by 80
Self-citationCurcumin’s Beneficial Effects on Neuroblastoma: Mechanisms, Challenges, and Potential Solutions
Zhai, K., Brockmueller, A., Kubatka, P., Shakibaei, M., & Büsselberg, D. (2020) · Biomolecules · doi:10.3390/biom10111469 · Cited by 80
Self-citationScinocca, M., Bell, D., Racapé, M., Joseph, R., Shaw, G., McCormick, J. K., Gladman, D. D., Pope, J. E., Barra, L., & Cairns, E. (2014) · The Journal of Rheumatology · doi:10.3899/jrheum.130742 · Cited by 79
How does abatacept really work in rheumatoid arthritis?
Bonelli, M. M., & Scheinecker, C. (2018) · Current Opinion in Rheumatology · doi:10.1097/bor.0000000000000491 · Cited by 79
Sieghart, D., Platzer, A., Studenic, P., Alasti, F., Grundhuber, M., Swiniarski, S., Horn, T. D., Haslacher, H., Blüml, S., Smolen, J. S., et al. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00876 · Cited by 78
Glycosylation as a marker for inflammatory arthritis
Albrecht, S., Unwin, L., Muniyappa, M., & Rudd, P. M. (2014) · Cancer Biomarkers · doi:10.3233/cbm-130373 · Cited by 76
Sorice, M., Iannuccelli, C., Manganelli, V., Capozzi, A., Alessandri, C., Lococo, E., Garofalo, T., Franco, M. D., Bombardieri, M., Nerviani, A., et al. (2016) · Rheumatology · doi:10.1093/rheumatology/kew178 · Cited by 76
Epigenetics in osteoarthritis: Potential of HDAC inhibitors as therapeutics
Khan, N. M., & Haqqi, T. M. (2017) · Pharmacological Research · doi:10.1016/j.phrs.2017.08.007 · Cited by 76
Evidence that TNF-β (lymphotoxin α) can activate the inflammatory environment in human chondrocytes
Buhrmann, C., Shayan, P., Aggarwal, B. B., & Shakibaei, M. (2013) · Arthritis Research & Therapy · doi:10.1186/ar4393 · Cited by 75
Self-citationSchuebel, K., Gitik, M., Domschke, K., & Goldman, D. (2016) · International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyw058 · Cited by 75
Sana, E., Zeeshan, M., Ain, Q., Khan, A. U., Hussaın, I., Khan, S., Lepeltier, É., & Ali, H. (2021) · Nanomedicine · doi:10.2217/nnm-2020-0316 · Cited by 75
Reed, E., Hedström, A. K., Hansson, M., Mathsson‐Alm, L., Brynedal, B., Saevarsdóttir, S., Cornillet, M., Jakobsson, P., Holmdahl, R., Skriner, K., et al. (2020) · Arthritis Research & Therapy · doi:10.1186/s13075-020-02191-2 · Cited by 73
Oh, B. R., Suh, D., Bae, D., Ha, N., Choi, Y. I., Yoo, H. J., Park, J. K., Lee, E. Y., Lee, E. B., & Song, Y. W. (2017) · Arthritis Research & Therapy · doi:10.1186/s13075-017-1357-2 · Cited by 72
Clinical Pharmacokinetics and Pharmacodynamics of Panobinostat
Veggel, M. V., Westerman, E. M., & Hamberg, P. (2017) · Clinical Pharmacokinetics · doi:10.1007/s40262-017-0565-x · Cited by 72
Abatacept for the treatment of rheumatoid arthritis
Pombo‐Suárez, M., & Gómez-Reino, J. J. (2019) · Expert Review of Clinical Immunology · doi:10.1080/1744666x.2019.1579642 · Cited by 67
Rheumatoid Arthritis Naive T Cells Share Hypermethylation Sites With Synoviocytes
Rhead, B., Holingue, C., Cole, M. B., Shao, X., Quach, H., Quach, D. L., Shah, K., Sinclair, E., Graf, J., Link, T. M., et al. (2016) · Arthritis & Rheumatology · doi:10.1002/art.39952 · Cited by 66
BAFF inhibition: A new class of drugs for the treatment of autoimmunity
Liu, Z., & Davidson, A. (2011) · Experimental Cell Research · doi:10.1016/j.yexcr.2011.02.005 · Cited by 65
Anti-citrullinated protein antibodies cause arthritis by cross-reactivity to joint cartilage
Ge, C., Tong, D., Liang, B., Lönnblom, E., Schneider, N., Hagert, C., Viljanen, J., Ayoglu, B., Stawikowska, R., Nilsson, P., et al. (2017) · JCI Insight · doi:10.1172/jci.insight.93688 · Cited by 65
Targeted inhibition of histone deacetylase 6 in inflammatory diseases
Ran, J., & Zhou, J. (2019) · Thoracic Cancer · doi:10.1111/1759-7714.12974 · Cited by 64
Behl, T., Kaur, I., Sehgal, A., Zengin, G., Brisc, C., Brisc, M. C., Munteanu, M. A., Nistor-Cseppento, C. D., & BUNGAU, S. G. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21249505 · Cited by 64
Immunometabolic Pathways and Its Therapeutic Implication in Autoimmune Diseases
Wang, T., Jiao, Y., & Zhang, X. (2020) · Clinical Reviews in Allergy & Immunology · doi:10.1007/s12016-020-08821-6 · Cited by 62
Solomon, D. H., Losina, E., Lü, B., Zak, A., Corrigan, C., Lee, S. B., Agosti, J., Bitton, A., Harrold, L. R., Pincus, T., et al. (2017) · Arthritis & Rheumatology · doi:10.1002/art.40111 · Cited by 59
Herrath, J., Chemin, K., Albrecht, I., Catrina, A. I., & Malmström, V. (2014) · European Journal of Immunology · doi:10.1002/eji.201344140 · Cited by 57
JAK inhibitors for the treatment of rheumatoid arthritis
Morinobu, A. (2020) · Immunological Medicine · doi:10.1080/25785826.2020.1770948 · Cited by 57
Systematic Review of Safety and Efficacy of Atacicept in Treating Immune-Mediated Disorders
Kaegi, C., Steiner, U. C., Wuest, B., Crowley, C., & Boyman, O. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.00433 · Cited by 57
Ireland, J. M., & Unanue, E. R. (2012) · Autophagy · doi:10.4161/auto.19261 · Cited by 56
Teitsma, X. M., Marijnissen, A. C. A., Bijlsma, J. W. J., Lafeber, F. P. J. G., & Jacobs, J. W. G. (2016) · Arthritis Research & Therapy · doi:10.1186/s13075-016-1108-9 · Cited by 55
Arnoux, F., Mariot, C., Peen, E., Lambert, N. C., Balandraud, N., Roudier, J., & Auger, I. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1713112114 · Cited by 55
Differential Anti-inflammatory Activity of HDAC Inhibitors in Human Macrophages and Rat Arthritis
Lohman, R., Iyer, A., Fairlie, T., Cotterell, A. J., Gupta, P. K., Reid, R. C., Vesey, D. A., Sweet, M. J., & Fairlie, D. P. (2015) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.115.229328 · Cited by 54
Abberant Immunoglobulin G Glycosylation in Rheumatoid Arthritis by LTQ-ESI-MS
Su, Z., Xie, Q., Wang, Y., & Li, Y. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21062045 · Cited by 54
Oral Microbiota Identifies Patients in Early Onset Rheumatoid Arthritis
Esberg, A., Johansson, L., Johansson, I., & Rantapää‐Dahlqvist, S. (2021) · Microorganisms · doi:10.3390/microorganisms9081657 · Cited by 54
Citrullination only infrequently impacts peptide binding to HLA class II MHC
Sidney, J., Bécart, S., Zhou, M., Duffy, K. E., Lindvall, M., Moore, E. C., Moore, E. L., Rao, T. S., Rao, N. L., Nielsen, M., et al. (2017) · PLoS ONE · doi:10.1371/journal.pone.0177140 · Cited by 53
Poonia, N., Lather, V., Kaur, B., Kirthanashri, S. V., & Pandita, D. (2020) · Assay and Drug Development Technologies · doi:10.1089/adt.2020.989 · Cited by 53
The Rheumatoid Arthritis Risk Gene LBH Regulates Growth in Fibroblast‐like Synoviocytes
Ekwall, A. H., Whitaker, J. W., Hammaker, D. R., Bugbee, W. D., Wang, W., & Firestein, G. S. (2015) · Arthritis & Rheumatology · doi:10.1002/art.39060 · Cited by 52
Bečanović, K., Jagodic, M., Sheng, J. R., Dahlman, I. A., Aboul‐Enein, F., Wallström, E., Olofsson, P., Holmdahl, R., Lassmann, H., & Olsson, T. P. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.10.6055 · Cited by 52
Histone deacetylase 1 (HDAC1): A key player of T cell-mediated arthritis.
Göschl, L., Preglej, T., Boucheron, N., Saferding, V., Müller, L., Platzer, A., Hirahara, K., Shih, H., Bäcklund, J., Matthias, P., et al. (2019) · Journal of Autoimmunity · doi:10.1016/j.jaut.2019.102379 · Cited by 52
Dai, S., Wang, B., Li, W., Wang, L., Song, X., Guo, C. H., Li, Y., Liu, F., Zhu, F., Wang, Q., et al. (2016) · Cell Death and Disease · doi:10.1038/cddis.2016.376 · Cited by 51
Epratuzumab for the treatment of systemic lupus erythematosus
Geh, D., & Gordon, C. (2018) · Expert Review of Clinical Immunology · doi:10.1080/1744666x.2018.1450141 · Cited by 51
Frequency of Th17 CD4+ T Cells in Early Rheumatoid Arthritis: A Marker of Anti-CCP Seropositivity
Arroyo-Villa, I., Bautista-Caro, M.-B., Balsa, A., Aguado, P., Nuño, L., Bonilla-Hernán, M.-G., Puig‐Kröger, A., Martín-Mola, E., & Miranda‐Carús, M. (2012) · PLoS ONE · doi:10.1371/journal.pone.0042189 · Cited by 48
The Rationale for BAFF Inhibition in Systemic Lupus Erythematosus
Davidson, A. (2012) · Current Rheumatology Reports · doi:10.1007/s11926-012-0258-2 · Cited by 48
Kirwan, J., Hickey, S., Hällgren, R., Mielants, H., Björck, E., Persson, T., & Wollheim, F. A. (2006) · Arthritis & Rheumatism · doi:10.1002/art.21747 · Cited by 47
Chemin, K., Pollastro, S., James, E. A., Ge, C., Albrecht, I., Herrath, J., Gerstner, C., Tandre, K., Rizzi, T. S., Rönnblom, L., et al. (2015) · Arthritis & Rheumatology · doi:10.1002/art.39553 · Cited by 47
Plasma cell-directed therapies in monoclonal gammopathy-associated scleromyxedema
Mahevas, T., Arnulf, B., Bouaziz, J., Livideanu, C. B., Osio, A., Servy, A., Cribier, B. J., Sassolas, B., Jachiet, M., Michel, L., et al. (2020) · Blood · doi:10.1182/blood.2019002300 · Cited by 46
Diomede, F., Fonticoli, L., Guarnieri, S., Rocca, Y. D., Rajan, T. S., Fontana, A., Trubiani, O., Marconi, G. D., & Pizzicannella, J. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22147534 · Cited by 46
Buhrmann, C., Honarvar, A., Setayeshmehr, M., Karbasi, S., Shakibaei, M., & Valiani, A. (2020) · Molecules · doi:10.3390/molecules25133075 · Cited by 44
Self-citationIwamoto, N., Sato, S., Kurushima, S., Michitsuji, T., Nishihata, S., Okamoto, M., Tsuji, Y., Endo, Y., Shimizu, T., Sumiyoshi, R., et al. (2021) · Arthritis Research & Therapy · doi:10.1186/s13075-021-02582-z · Cited by 44
Targeting the CD40-CD154 Signaling Pathway for Treatment of Autoimmune Arthritis
Lai, J., Luo, S., & Ho, L. (2019) · Cells · doi:10.3390/cells8080927 · Cited by 42
Shabgah, A. G., Shariati‐Sarabi, Z., Tavakkol‐Afshari, J., Ghasemi, A., Ghoryani, M., & Mohammadi, M. (2020) · Gene · doi:10.1016/j.gene.2020.144336 · Cited by 42
Curcumin and folic acid abrogated methotrexate induced vascular endothelial dysfunction
Sankrityayan, H., & Majumdar, A. S. (2015) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/cjpp-2015-0156 · Cited by 40
Comprehensive Profiling of the Rheumatoid Arthritis Antibody Repertoire
Lo, K. C., Sullivan, E. H., Bannen, R. M., Jin, H., Rowe, M., Li, H., Pinapati, R. S., Cartwright, A. J., Tan, J. C., Patel, J., et al. (2019) · Arthritis & Rheumatology · doi:10.1002/art.41089 · Cited by 40
Emerging glyco‐based strategies to steer immune responses
Anderluh, M., Berti, F., Bzducha‐Wróbel, A., Chiodo, F., Colombo, C., Compostella, F., Durlik-Popińska, K., Ferhati, X., Holmdahl, R., Jovanović, D. J., et al. (2021) · FEBS Journal · doi:10.1111/febs.15830 · Cited by 39
How does B cell depletion therapy work, and how can it be improved?
Clark, E. A., & Ledbetter, J. A. (2005) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2005.042507 · Cited by 38
Reporters of TCR signaling identify arthritogenic T cells in murine and human autoimmune arthritis
Ashouri, J. F., Hsu, L., Yu, S., Rychkov, D., Chen, Y., Cheng, D. A., Sirota, M., Hansen, E., Lattanza, L. L., Zikherman, J., et al. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1904271116 · Cited by 36
Autophagy, a new determinant of plasma cell differentiation and antibody responses
Cenci, S. (2014) · Molecular Immunology · doi:10.1016/j.molimm.2014.02.008 · Cited by 34
Giltiay, N. V., Shu, G. L., Shock, A., & Clark, E. A. (2017) · Arthritis Research & Therapy · doi:10.1186/s13075-017-1284-2 · Cited by 33
de la Calle‐Fabregat, C., Niemantsverdriet, E., Cañete, J. D. D., Li, T., Mil, A. H. M. V. D. H., Rodríguez‐Ubreva, J., & Ballestar, E. (2021) · Arthritis & Rheumatology · doi:10.1002/art.41885 · Cited by 32
Buhrmann, C., Brockmueller, A., Harsha, C., Kunnumakkara, A. B., Kubatka, P., Aggarwal, B. B., & Shakibaei, M. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.699842 · Cited by 32
Self-citationThe “Treat to Target” Approach to Rheumatoid Arthritis
Salomon-Escoto, K., & Kay, J. (2019) · Rheumatic Disease Clinics of North America · doi:10.1016/j.rdc.2019.06.001 · Cited by 31
Hultqvist, M. H., Sareila, O., Vilhardt, F., Norin, U., Olsson, L. M., Olofsson, P., Hellman, U., & Holmdahl, R. (2011) · Antioxidants and Redox Signaling · doi:10.1089/ars.2010.3440 · Cited by 30
Zhang, X., Chua, L., Ernest, C. S., Macias, W. L., Rooney, T. P., & Tham, L. S. (2017) · CPT Pharmacometrics & Systems Pharmacology · doi:10.1002/psp4.12251 · Cited by 30
Adalimumab for rheumatoid arthritis
Voulgari, P. V., & Drosos, A. A. (2006) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.6.12.1349 · Cited by 28
Emerging epigenetic targets in rheumatoid arthritis
Barik, R. R., & Bhatt, L. K. (2021) · Rheumatology International · doi:10.1007/s00296-021-04951-y · Cited by 27
Molecular epigenetic switches in neurodevelopment in health and disease
Hoffmann, A., Zimmermann, C. A., & Spengler, D. (2015) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2015.00120 · Cited by 25
Affinity maturation and characterization of the ofatumumab monoclonal antibody
Payandeh, Z., Rajabibazl, M., Mortazavi, Y., Rahimpour, A., Taromchi, A. H., & Dastmalchi, S. (2018) · Journal of Cellular Biochemistry · doi:10.1002/jcb.27457 · Cited by 25
Self-citationAlghadir, A. H., Miraj, M., & Ali, S. A. (2020) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2020/4606520 · Cited by 25
Tsai, C., Hsieh, S., Liu, C., Lu, C., Liao, H., Chen, M., Li, K., Wu, C.-H., Shen, C.-Y., Kuo, Y., et al. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22115689 · Cited by 25
Variable domain glycosylation of ACPA-IgG: A missing link in the maturation of the ACPA response?
Kempers, A. C., Hafkenscheid, L., Scherer, H. U., & Toes, R. E. M. (2017) · Clinical Immunology · doi:10.1016/j.clim.2017.09.001 · Cited by 22
Reyes-Castillo, Z., Muñóz-Valle, J. F., & Llamas-Covarrubias, M. A. (2017) · Autoimmunity Reviews · doi:10.1016/j.autrev.2017.11.023 · Cited by 22
Hemshekhar, M., Anaparti, V., El-Gabalawy, H. S., & Mookherjee, N. (2021) · Arthritis Research & Therapy · doi:10.1186/s13075-021-02423-z · Cited by 22
Fleischmann, R., Genovese, M. C., Maslova, K., Leher, H., Praestgaard, A. H., & Burmester, G. R. (2021) · Rheumatology · doi:10.1093/rheumatology/keab355 · Cited by 21
Li, R., Wang, T., Bird, S., Zou, J., Dooley, H. M., & Secombes, C. J. (2013) · Fish & Shellfish Immunology · doi:10.1016/j.fsi.2013.02.015 · Cited by 20
Xu, S., & Lam, K. (2020) · Cancers · doi:10.3390/cancers12041045 · Cited by 20
Genetic variant in microRNA-146a gene is associated with risk of rheumatoid arthritis
Zhang, L., Wu, X.-X., Wang, X., Di, D., Huang, Q., Liu, R., Shuai, Z., Ye, D., & Leng, R. (2021) · Annals of Medicine · doi:10.1080/07853890.2021.1933163 · Cited by 20
Xie, P., Xue, W., Qi, W., Li, Y., Yang, L., Yang, Z., & Shi, A. (2021) · Drug Design Development and Therapy · doi:10.2147/dddt.s294849 · Cited by 18
Where to Stand with Stromal Cells and Chronic Synovitis in Rheumatoid Arthritis?
Brondello, J., Djouad, F., & Jørgensen, C. (2019) · Cells · doi:10.3390/cells8101257 · Cited by 17
CCR6 controls autoimmune but not innate immunity‐driven experimental arthritis
Bonelli, M. M., Puchner, A., Göschl, L., Hayer, S., Niederreiter, B., Steiner, G. E., Tillmann, K. E., Plasenzotti, R., Podesser, B. K., Georgel, P., et al. (2018) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.13783 · Cited by 16
Bae, S., & Lee, Y. H. (2018) · International Journal of Rheumatic Diseases · doi:10.1111/1756-185x.13305 · Cited by 15
Endophilin A2 deficiency protects rodents from autoimmune arthritis by modulating T cell activation
Norin, U., Rintisch, C., Meng, L., Forster, F., Ekman, D. S., Tuncel, J., Klocke, K., Bäcklund, J., Yang, M., Bonner, M. Y., et al. (2021) · Nature Communications · doi:10.1038/s41467-020-20586-2 · Cited by 14
Villa-Hermosilla, M.-C., Fernández-Carballido, A. M., Hurtado, C., Barcia, E., Montejo, C., Alonso, M., & Negro, S. (2021) · Pharmaceutics · doi:10.3390/pharmaceutics13070951 · Cited by 13
Co-stimulatory blockade as therapy for rheumatoid arthritis
Mackie, S. L., Vital, E. M. J., Ponchel, F., & Emery, P. (2005) · Current Rheumatology Reports · doi:10.1007/s11926-005-0029-4 · Cited by 12
Durkin, A., Vu, H.-Y. T., & Lee, H. (2020) · The Journal of Immunology · doi:10.4049/jimmunol.1900531 · Cited by 12
Stacy, J. M., Greenmyer, J. R., Beal, J. R., Sahmoun, A. E., & Diri, E. (2021) · Revista Brasileira de Reumatologia · doi:10.1186/s42358-021-00205-4 · Cited by 12
Hiepe, F., Alexander, T., & Voll, R. E. (2015) · Zeitschrift für Rheumatologie · doi:10.1007/s00393-014-1438-4 · Cited by 10
Co-stimulation Therapy in Rheumatoid Arthritis: Today and Tomorrow
Schiff, M. H. (2015) · Current Treatment Options in Rheumatology · doi:10.1007/s40674-015-0029-0 · Cited by 9
Cell-Specific Epigenetic Drivers of Pathogenesis in Rheumatoid Arthritis
Nair, N., Barton, A. C., & Wilson, A. G. (2021) · Epigenomics · doi:10.2217/epi-2020-0380 · Cited by 7
Shigeyama (2000) · doi:10.1002/1529-0131(200011)43:11
Cited by
Signaling pathways in rheumatoid arthritis: implications for targeted therapy
Ding, Q., Hu, W., Wang, R., Yang, Q., Zhu, M., Li, M., Cai, J., Rose, P., Mao, J., & Zhu, Y. Z. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01331-9 · Cited by 478
Metadata
- Authors
- Mueller, A.-L., Payandeh, Z., Mohammadkhani, N., Mubarak, S. M. H., Zakeri, A., Alagheband Bahrami, A., Brockmueller, A., & Shakibaei, M.
- Venue
- Cells
- Publisher
- MDPI AG
- Published
- 2021-11-04
- Volume
- 10
- Issue
- 11
- Pages
- 3017
- ISSN
- 2073-4409 (ISSN-L)
- OpenAlex
- W3211749040
- Cited by
- 256
- References
- 299
- FWCI
- 21.55
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.